Trial intelligence / Profile preview

Domperidone in Refractory Gastroparesis

NCT00760461Phase 2Terminated

Sponsor
Yale University
Start
Oct 2008
Primary completion
Jul 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of domperidone in gastroparesis, sponsored by Yale University. Started Oct 2008; status: terminated.

02

Drugs

domperidone
03

Conditions

gastroparesis

Beyond the preview

Go deeper on NCT00760461.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00760461.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call